Oculomics for the Next Billion — From Eye Care to Life Care

At Remidio, we believe eyesight is more than vision: it is a window into whole-body health and wellness. Our pioneering oculomics platform harnesses AI and innovative imaging to democratize health screening—so every eye exam can protect lives.

Proprietary Data Moat that Enables us to rapidly develop new AIs

7M

multi-ethnic datapoints in our Data Base

From Multiple clinical touchpoints

Ophthalmology, Primary care, Cardiology, Diabetology, Endocrinology

Multimodal Data

Blood Proteome, Oculome, CT, Angio, 2D Echo

Oculomics

A Paradigm Shift in Global Health

Oculomics for the Next Billion

The Eye’s Window to Preventive Care

Oculomics is revolutionizing healthcare—shifting the focus from reacting to overt disease, to proactive and predictive screening.
Routine eye scans, powered by Remidio’s AI, are converging with broader health monitoring, blurring the boundaries between ophthalmology, optometry, and primary care so systemic diseases can be tracked non-invasively.No longer just for privileged health systems, oculomics is now a practical path to early detection of diabetes, cardiovascular risk, kidney disorders, liver disease, anemia, PE, and more, from a single eye exam.

The Eye as a Gateway to Whole-Body Health

Cardiovascular Risk

Retinal imaging powered by Remidio’s MediosHI AI delivers real-time, cost-effective cardiovascular risk assessments—making heart health checks accessible everywhere.

Kidney & Metabolic Risk

AI analysis of retinal images detects elevated risk of chronic kidney disease, diabetes complications, and other systemic conditions early, before symptoms appear.

Maternity Health

AI-powered retinal imaging can serve as a non-invasive window into maternal vascular health, enabling early detection of risks like gestational diabetes and preeclampsia. This opens a scalable pathway for integrating maternal risk screening into antenatal care programs across both urban and rural settings.

Neurological Health

Eye biomarkers reflect changes linked to brain health. Oculomics enables non-invasive monitoring of early signs of stroke, dementia, and other neurological risks.

Remidio leverages proprietary on-the-edge AI & novel imaging technologies that enable Screening - Anywhere, Anytime

Cardiovascular Risk

Presence/Absence of more than mild CKD

Presence/Absence of Obstructive CAD

Mobile Innovation and Edge AI — Oculomics Where It’s Needed Most

Remidio’s patented, smartphone-enabled hardware provides high-quality retinal images in any setting, rural, urban, mobile. With OnEdge AI, all analysis and reporting happens instantly, offline, and in-clinic, no cloud required, ensuring patient privacy and rapid results. Our evolving portfolio expands beyond DR, AMD, and glaucoma to CVD risk, CKD, liver and blood disorders, all deployable with minimal training.

Certifications

End-to-End Integration for Every Clinical Workflow

Oculomics for the Next Billion works across care silos, allowing primary care, optometry, and ophthalmology teams to collaborate on predictive screening, early triage, and streamlined referrals.

Routine eye exams now become part of general health screening, helping providers act earlier and prevent costly, late-stage complications.

Collaborate

Primary care, optometry, and ophthalmology teams working together on predictive screening

Triage

Identify risks early and route patients efficiently

Refer

Streamline referrals for faster access to care

Prevent

Turn routine eye exams into powerful tools for early intervention

Proactive Health for the Next Billion

Remidio’s oculomics vision is to bring predictive, preventive health to populations who need it most.

Routine Health Screening

Routine eye scans can now be part of general health screening. This shifts eye exams into mainstream preventive care.

Global Adoption

Our mobile, affordable, and locally validated platform is being adopted in nationwide health programs, government missions, and public-private pilots across 40+ countries.

Scaling Access

15+

Public - Private Partnerships

20+

National Health Programs

40+

Countries Impacted

Building the Data Moat

Remidio is forging partnerships and creating the data infrastructure needed to make oculomics scale for billions.

Oculomics in Action Stories from the Field

Remidio made it possible for me, as an optometrist, to flag patients’ whole health risk—not just vision. That’s real impact.

Mobile edge AI means I can reach remote communities with early disease checks. It’s hope delivered, not just a diagnosis.

Proactive Health for the Next Billion

Scalable Platform

Enabling predictive health through mobile, affordable, and locally validated oculomics technology.

Global Adoption

Adopted in nationwide health programs, public–private pilots, and government missions across 40+ countries.

Preventive Health

Making routine eye scans part of general health screening to predict and prevent systemic diseases.